Article · 13 Feb 2026
Conference abstractPublished 26 Jun 2017
New anti-inflammatory compounds from old medicines: The science and art of Pharmacognosy research in the 21st century
University of Greenwich, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
For thousands of years, mankind has used nature as a source of medicine. Despite the tremendous advances in medicinal chemistry and/or drug discovery areas over the years, our modern pharmacy even today employs a significant number of drugs that trace their origin back to natural products. Inflammatory diseases, especially chronic disorders such as arthritis, inflammatory bowel disease, psoriasis, sepsis, etc., continue to be a burden to large number of people and national health services throughout the world. With the severe limitations of the existing anti-inflammatory drugs (e.g. cost, side effects and efficacy) for such diseases, the appetite for novel drugs is as great as ever. During the past three decades, our researches have been mainly focusing on the identification of novel pharmacologically active compounds from medicinal plants. By using the bioassay-guided isolation approach, we have identified numerous compounds that showed potential in the various experimental models. In this communication, case examples are presented where the anti-inflammatory potential of crude and purified natural products have been validated through cell-free, cell-based and animal models of inflammation.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Solomon Habtemariam”
